Circulatory mitochondrial DNA is a pro-inflammatory agent in maintenance hemodialysis patients

PLoS ONE

Volumn 9, Issue 12, 2014, Pages

  Cao, Hongdi ^a   Ye, Hong ^a   Sun, Zhiping ^a   Shen, Xia ^a   Song, Zongwei ^a   Wu, Xiaochun ^a   He, Weichun ^a   Dai, Chunsun ^a   Yang, Junwei ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; C REACTIVE PROTEIN; CALCIUM; HEMOGLOBIN; INTERLEUKIN 6; MITOCHONDRIAL DNA; PHOSPHORUS; TUMOR NECROSIS FACTOR ALPHA; AUTACOID; CYTOKINE;

ADULT; ALBUMIN BLOOD LEVEL; ARTICLE; CALCIUM BLOOD LEVEL; CHRONIC INFLAMMATION; CONTROLLED STUDY; CYTOKINE RELEASE; DISEASE MARKER; FEMALE; HEMODIAFILTRATION; HEMODIALYSIS; HEMODIALYSIS PATIENT; HEMOGLOBIN BLOOD LEVEL; HUMAN; HUMAN CELL; IN VITRO STUDY; MAJOR CLINICAL STUDY; MALE; PHOSPHATE BLOOD LEVEL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; TREATMENT DURATION; ADVERSE EFFECTS; BLOOD; CASE CONTROL STUDY; CELL LINE; MIDDLE AGED; RENAL REPLACEMENT THERAPY; RISK FACTOR;

ADULT; CASE-CONTROL STUDIES; CELL LINE; CYTOKINES; DNA, MITOCHONDRIAL; FEMALE; HEMODIAFILTRATION; HUMANS; INFLAMMATION MEDIATORS; MALE; MIDDLE AGED; RENAL DIALYSIS; RISK FACTORS;

EID: 84915745862     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0113179     Document Type: Article

References (34)

1. Hung A, Pupim L, Yu C, Shintani A, Siew E, et al. (2008) Determinants of C-reactive protein in chronic hemodialysis patients: relevance of dialysis catheter utilization. Hemodial Int 12: 236-243.
2. Stenvinkel P, Carrero JJ, Axelsson J, Lindholm B, Heimburger O, et al. (2008) Emerging biomarkers for evaluating cardiovascular risk in the chronic kidney disease patient: how do new pieces fit into the uremic puzzle? Clin J Am Soc Nephrol 3: 505-521.
3. Kimmel PL, Phillips TM, Simmens SJ, Peterson RA, Weihs KL, et al. (1998) Immunologic function and survival in hemodialysis patients. Kidney Int 54: 236-244.
4. Malaponte G, Bevelacqua V, Fatuzzo P, Rapisarda F, Emmanuele G, et al. (2002) IL-1beta, TNF-alpha and IL-6 release from monocytes in haemodialysis patients in relation to dialytic age. Nephrol Dial Transplant 17: 1964-1970.
5. Morena M, Delbosc S, Dupuy AM, Canaud B, Cristol JP (2005) Overproduction of reactive oxygen species in end-stage renal disease patients: a potential component of hemodialysis-associated inflammation. Hemodial Int 9: 37-46.
6. Caglar K, Peng Y, Pupim LB, Flakoll PJ, Levenhagen D, et al. (2002) Inflammatory signals associated with hemodialysis. Kidney Int 62: 1408-1416.
7. Arizono K, Nomura K, Motoyama T, Matsushita Y, Matsuoka K, et al. (2004) Use of ultrapure dialysate in reduction of chronic inflammation during hemodialysis. Blood Purif 22 Suppl 2: 26-29.
8. Duranton F, Cohen G, De Smet R, Rodriguez M, Jankowski J, et al. (2012) Normal and pathologic concentrations of uremic toxins. J Am Soc Nephrol 23: 1258-1270.
9. Taanman JW (1999) The mitochondrial genome: structure, transcription, translation and replication. Biochim Biophys Acta 1410: 103-123.
10. Zhang Q, Raoof M, Chen Y, Sumi Y, Sursal T, et al. (2010) Circulating mitochondrial DAMPs cause inflammatory responses to injury. Nature 464: 104-107.
11. Oka T, Hikoso S, Yamaguchi O, Taneike M, Takeda T, et al. (2012) Mitochondrial DNA that escapes from autophagy causes inflammation and heart failure. Nature 485: 251-255.
12. Puskarich MA, Shapiro NI, Trzeciak S, Kline JA, Jones AE (2012) Plasma levels of mitochondrial DNA in patients presenting to the emergency department with sepsis. Shock 38: 337-340.
13. Tovbin D, Novack V, Wiessman MP, Abd Elkadir A, Zlotnik M, et al. (2012) Circulating cell-free DNA in hemodialysis patients predicts mortality. Nephrol Dial Transplant 27: 3929-3935.
14. Atamaniuk J, Kopecky C, Skoupy S, Saemann MD, Weichhart T (2012) Apoptotic cell-free DNA promotes inflammation in haemodialysis patients. Nephrol Dial Transplant 27: 902-905.
15. Tsai NW, Lin TK, Chen SD, Chang WN, Wang HC, et al. (2011) The value of serial plasma nuclear and mitochondrial DNA levels in patients with acute ischemic stroke. Clin Chim Acta 412: 476-479.
16. Chiu RW, Chan LY, Lam NY, Tsui NB, Ng EK, et al. (2003) Quantitative analysis of circulating mitochondrial DNA in plasma. Clin Chem 49: 719-726.
17. Krauss S, Zhang CY, Scorrano L, Dalgaard LT, St-Pierre J, et al. (2003) Superoxide-mediated activation of uncoupling protein 2 causes pancreatic beta cell dysfunction. J Clin Invest 112: 1831-1842.
18. Zhang Q, Itagaki K, Hauser CJ (2010) Mitochondrial DNA is released by shock and activates neutrophils via p38 map kinase. Shock 34: 55-59.
19. Brand K, Fowler BJ, Edgington TS, Mackman N (1991) Tissue factor mRNA in THP-1 monocytic cells is regulated at both transcriptional and posttranscriptional levels in response to lipopolysaccharide. Mol Cell Biol 11: 4732-4738.
20. Levey AS, Coresh J, Balk E, Kausz AT, Levin A, et al. (2003) National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med 139: 137-147.
21. Nolan CR (2005) Strategies for improving long-term survival in patients with ESRD. J Am Soc Nephrol 16 Suppl 2: S120-127.
22. Stenvinkel P, Wanner C, Metzger T, Heimburger O, Mallamaci F, et al. (2002) Inflammation and outcome in end-stage renal failure: does female gender constitute a survival advantage? Kidney Int 62: 1791-1798.
23. Zimmermann J, Herrlinger S, Pruy A, Metzger T, Wanner C (1999) Inflammation enhances cardiovascular risk and mortality in hemodialysis patients. Kidney Int 55: 648-658.
24. Hung AM, Ellis CD, Shintani A, Booker C, Ikizler TA (2011) IL-1beta receptor antagonist reduces inflammation in hemodialysis patients. J Am Soc Nephrol 22: 437-442.
25. Sun S, Sursal T, Adibnia Y, Zhao C, Zheng Y, et al. (2013) Mitochondrial DAMPs increase endothelial permeability through neutrophil dependent and independent pathways. PLoS One 8: e59989.
26. Nakahira K, Kyung SY, Rogers AJ, Gazourian L, Youn S, et al. (2013) Circulating mitochondrial DNA in patients in the ICU as a marker of mortality: derivation and validation. PLoS Med 10: e1001577; discussion e1001577.
27. Zhang L, Wang F, Wang L, Wang W, Liu B, et al. (2012) Prevalence of chronic kidney disease in China: a cross-sectional survey. Lancet 379: 815-822.
28. Sursal T, Stearns-Kurosawa DJ, Itagaki K, Oh SY, Sun S, et al. (2013) Plasma bacterial and mitochondrial DNA distinguish bacterial sepsis from sterile systemic inflammatory response syndrome and quantify inflammatory tissue injury in nonhuman primates. Shock 39: 55-62.
29. Kung CT, Hsiao SY, Tsai TC, Su CM, Chang WN, et al. (2012) Plasma nuclear and mitochondrial DNA levels as predictors of outcome in severe sepsis patients in the emergency room. J Transl Med 10: 130.
30. Che R, Yuan Y, Huang S, Zhang A (2014) Mitochondrial dysfunction in the pathophysiology of renal diseases. Am J Physiol Renal Physiol 306: F367-378.
31. Rao M, Li L, Demello C, Guo D, Jaber BL, et al. (2009) Mitochondrial DNA injury and mortality in hemodialysis patients. J Am Soc Nephrol 20: 189-196.
32. Korabecna M, Pazourkova E, Horinek A, Mokrejsova M, Tesar V (2012) Alterations in methylation status of immune response genes promoters in cell-free DNA during a hemodialysis procedure. Expert Opin Biol Ther 12 Suppl 1: S27-33.
33. Cunningham J, Locatelli F, Rodriguez M (2011) Secondary hyperparathyroidism: pathogenesis, disease progression, and therapeutic options. Clin J Am Soc Nephrol 6: 913-921.
34. Jourde-Chiche N, Dou L, Cerini C, Dignat-George F, Vanholder R, et al. (2009) Protein-bound toxins-update 2009. Semin Dial 22: 334-339.